5.5
Reações de Fase I: Reações Redutivas
As reações redutivas de biotransformação de Fase I são processos químicos que modificam medicamentos introduzindo ou revelando grupos funcionais polar…
As reações redutoras introduzem elétrons nas moléculas do medicamento, afetando grupos funcionais polares como hidroxi e amino, permitindo a subsequente biotransformação ou conjugação.
As reduções do grupo carbonila transformam compostos carbonílicos alifáticos e cetonas aromáticas e alicíclicas em álcoois. Por exemplo, a naltrexona se transforma em seu derivado de isomorfina.
As reduções C = C, como visto em esteróides como a noretindrona, convertem ligações duplas em ligações simples. Os álcoois sofrem desidratação em alcenos antes da redução, como exemplificado pelos metabólitos do medicamento antiespasmódico benciclano.
As reduções de compostos N transformam os grupos nitro, azo e N-óxido em suas formas reduzidas. Por exemplo, a redução de nitro no nitrazepam ocorre por meio de intermediários nitrosos e hidroxilaminas para produzir uma amina.
O prontosil, um medicamento azo, sofre redução para sulfanilamida ativa, enquanto o N-óxido de imipramina é convertido em imipramina.
Diversas reações redutoras abrangem vários processos de redução no metabolismo de drogas.
O anestésico halotano sofre desalogenação redutora e é convertido em ácido trifluoroacético ou seus derivados.
View the full transcript and gain access to JoVE Core videos
Q1: What is the main purpose of reductive reactions in drug metabolism?
Reductive reactions introduce electrons to drug molecules, modifying lipophilic drugs by introducing or revealing polar functional groups. Enzymes called reductases catalyze these reactions, transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. This process is essential for drug detoxification and elimination from the body.
Q2: How do carbonyl group reductions work in drug metabolism?
Carbonyl group reduction is an essential reductive reaction where aldehydes and ketones are reduced to alcohols. For example, naltrexone transforms into its isomorphine derivative through this process. Enzymes like aldehyde dehydrogenase catalyze the conversion of acetaldehyde to ethanol, demonstrating how carbonyl compounds are enzymatically reduced to their alcohol forms.
Q3: What happens to carbon-carbon double bonds during reductive drug metabolism?
Carbon-carbon double bonds are reduced to single bonds through enzymatic processes. Steroids like norethindrone undergo C=C reductions, converting their double bonds into single bonds. Enzymes like cytochrome P450 reductase catalyze these transformations, making drugs more water-soluble for subsequent biotransformation or conjugation.
Q4: How are nitro and azo compounds reduced during phase I metabolism?
Nitro groups are reduced to amino groups through nitroreductase enzymes, proceeding via nitroso and hydroxylamine intermediates. For instance, nitrazepam undergoes nitro reduction to yield an amine. Azo compounds like prontosil are reduced by azoreductases to active metabolites such as sulfanilamide, demonstrating how N-compounds transform during drug metabolism.
Q5: What role do N-oxide reductions play in drug biotransformation?
N-oxide reductions convert N-oxide groups to their reduced forms, representing an important class of reductive reactions. Imipramine N-oxide is converted to imipramine through this process. These reductions help modify drug structure and enhance water solubility, facilitating subsequent phase II conjugation reactions for drug elimination.
Q6: What are examples of miscellaneous reductive reactions in drug metabolism?
Miscellaneous reductive reactions encompass various reduction processes beyond carbonyl and double bond modifications. The anesthetic halothane undergoes reductive dehalogenation, converting to trifluoroacetic acid or its derivatives. These diverse reductive pathways demonstrate how different functional groups can be modified through enzymatic reduction to facilitate drug detoxification.
Q7: How do reductive reactions prepare drugs for subsequent biotransformation steps?
Reductive reactions introduce or reveal polar functional groups on drug molecules, creating reactive sites for subsequent biotransformation or conjugation. By converting lipophilic drugs into more polar, water-soluble metabolites, these reactions facilitate the action of phase II enzymes. This sequential modification process is critical for complete drug metabolism and efficient elimination from the body.